Tesamorelin (GHRH Analogue)

Clarity Biologix – Tesamorelin Research Peptide

For Research Purposes Only | Not for Human or Veterinary Use

Product Specifications

Purity: ≥99%, verified via third-party HPLC testing
Form: Sterile, lyophilized powder in sealed vials
Dosage Options: 5 mg or 10 mg per vial

Storage:
Lyophilized powder: store at –20 °C (short-term: 2–8 °C)
Reconstituted solution: refrigerate at 2–8 °C and shield from light.

Key Research Applications

• GH Axis Modeling — Investigate GHRH receptor activation, pulsatile GH release, and downstream signaling such as cAMP pathways.
• Metabolic Studies — Preclinical research on visceral fat reduction, lipid metabolism, and insulin sensitivity. Notably shown to reduce visceral adipose tissue (VAT) by ~15–20% in clinical-style trials.
• Advanced Endocrine Research — Applicable in studying neuroendocrine feedback loops, IGF-1 modulation, and GH-mediated metabolic rebalancing.

Compliance & Legal Notice

For Research Use Only — Not intended for human or veterinary use. No therapeutic claims are made.

Regulatory Compliance — Copy avoids medical or diagnostic language to align with FDA/FTC guidelines.

Terms of Sale — Purchase confirms you are a qualified researcher or institution. All liability for use and storage rests with the buyer.

Prohibited Uses — Not for drug compounding or administration to living subjects. Clarity Biologix disclaims any misuse and may refuse sale accordingly.

Liability Statement — Buyer assumes all responsibility; Clarity Biologix held harmless in case of misuse.

Why Choose Clarity Biologix’s Tesamorelin?

• High Purity & Stability — ≥99% purity ensures consistency across preclinical protocols.
• Proven Research Relevance — Effectively used in studies on visceral fat, GH axis signaling, and metabolic regulation.
• Optimized Formulation — Two dosage strengths offer flexibility for diverse experimental designs.
• Compliance-Oriented Branding — Research-only presentation ensures alignment with best practices and reduces regulatory risk.

Frequently Asked Questions (FAQs)

Q: Is Tesamorelin approved for clinical or human use?
A: No. While tesamorelin is FDA-approved (as Egrifta) for HIV-associated lipodystrophy, Clarity Biologix’s version is strictly for in vitro/preclinical research.

Q: Has this product been FDA evaluated?
A: No. It is intended only for laboratory research. The product description avoids implying clinical utility.

Q: How do I verify purity or composition?
A: A Certificate of Analysis (CoA) citing ≥99% purity is available upon request.

Q: How should I store the reconstituted peptide?
A: Keep refrigerated at 2–8 °C and protected from light to preserve stability.